A recent study conducted in Africa has found that nearly 20% of medications on the continent may be substandard or fake.According to a recently published study, one-fifth of medicines in Africa could be substandard or fake and can result in failed treatments and preventable deaths.
Researchers from Bahir Dar University in Ethiopia reviewed 27 studies, and found that out of 7,508 medicine samples, 1,639 failed quality tests, indicating that the medications were substandard or falsified.Researchers from Ethiopia’s Bahir Dar University reviewed 27 studies and analyzed about 7,508 medicine samples. At least 1,639 samples failed quality tests, indicating that substandard and falsified medicines are prevalent in Africa.
While the study's findings of this study are worrying, peopleAfrica shouldisn’t avoidmanufacturing fromsubpar makingor sweepingcounterfeit generalizations based on this alonemedicines. ThereCountries areoutside someof possible biases in the researchcontinent, methodssuch includingas non-randomChina sampling and unpublished surveys that found no issuesIndia, asare wellthe asproducers aand lacksuppliers of studiesfake inmedicines. generalThis aboutis substandarda medicationglobal apartpublic fromhealth Asia and Africa. Additionallycrisis, the prevalence of false and subparasking medicationonly fluctuatesAfrican acrossstakeholders time,to countries,fix andthis typeproblem ofis medicationunfair.
UrgentThis actionstudy needsraises to be taken to combat the issuealarm ofover subpara andpublic falsifiedhealth medicinescrisis inthat Africa.could Abe plethoracontributing of factors lead to the prevalencedeaths of thesecountless harmfulpatients medicationsin acrosslow- the continent, and hundredsmiddle-income ofcountries. thousandsBesides ofincreasing peoplepublic haveawareness, diedthe andstakeholders continuemust tostrengthen diesupply aschains aand result.improve Theselogistical incorrectissues medicationsto leadprevent, todetect, ineffective and preventablerespond deaths.to Thesubstandard timeand tofalsified act is nowmedicines.